Technology
10x Genomics Reports First Quarter 2026 Financial Results
Published
2 months agoon
By
PLEASANTON, Calif., May 7, 2026 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2026.
Recent Updates
Revenue was $150.8 million for the first quarter of 2026, representing a 3% decrease over the corresponding period of 2025. Excluding $16.8 million related to one-time license and royalty revenue in the first quarter of 2025, revenue increased 9% over the corresponding period of 2025.Launched Atera, a new platform to redefine how biology is measured and understood. Atera was engineered to deliver spatial whole-transcriptome analysis with single-cell sensitivity at unprecedented scale. The Company expects to start shipping Atera in the second half of 2026.Announced a partnership with Bioptimus, a global AI biotech company, to launch STELA, a multinational spatial data generation initiative to create foundational datasets connecting underlying biology with disease outcomes. The initiative is starting this effort on our Xenium platform and plans to expand to Atera over time.Ended the first quarter of 2026 with cash and cash equivalents and marketable securities of $539.8 million, representing a $112.9 million increase from March 31, 2025.
“We had a solid start to the year, with double-digit growth in Single Cell consumables reaction volumes and double-digit growth in Spatial consumables revenue,” said Serge Saxonov, Co-founder and CEO of 10x Genomics. “The biggest highlight is our recent launch of Atera, which represents the most significant product introduction in our history. We are extremely encouraged by the extraordinary early customer response.”
First Quarter 2026 Financial Results
Revenue was $150.8 million for the first quarter of 2026, a 3% decrease from the corresponding period of 2025. Excluding $16.8 million related to a patent litigation settlement recognized in the first quarter of 2025, revenue increased 9% over the corresponding period of 2025.
Gross margin was 70% for the first quarter of 2026, as compared to 68% for the corresponding prior year period. The increase in gross margin was primarily due to lower warranty costs and lower inventory write-downs, partially offset by a decrease in license and royalty revenue reflecting a non-recurring royalty benefit recognized in the first quarter of 2025.
Operating expenses were $123.2 million for the first quarter of 2026, a 15% decrease from $144.8 million for the corresponding prior year period. The decrease was primarily driven by lower outside legal expenses and personnel expenses, partially offset by a non-recurring gain on settlement of $9.2 million recognized in the first quarter of 2025.
Operating loss was $17.0 million for the first quarter of 2026, as compared to operating loss of $39.3 million for the corresponding prior year period.
Net loss was $13.5 million for the first quarter of 2026, as compared to a net loss of $34.4 million for the corresponding prior year period.
Cash and cash equivalents and marketable securities were $539.8 million as of March 31, 2026.
2026 Financial Guidance
10x Genomics is maintaining its full year 2026 revenue guidance of $600 million to $625 million. Excluding the non-recurring license and royalty revenue related to patent litigation settlements in 2025, this represents 0% to 4% growth over full year 2025.
Webcast and Conference Call Information
10x Genomics will host a conference call to discuss the first quarter 2026 financial results, business developments and outlook after market close on Thursday, May 7, 2026 at 1:30 PM Pacific Time / 4:30 PM Eastern Time. A webcast of the conference call can be accessed at http://investors.10xgenomics.com. The webcast will be archived and available for replay at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world’s understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections. All statements included in this press release, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “might,” “will,” “should,” “expect,” “plan,” “outlook,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “see,” “estimate,” “predict,” “potential,” “would,” “likely,” “seek” or “continue” or the negatives of these terms or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding 10x Genomics, Inc.’s products, services, business strategy, collaborations and opportunities and 10x Genomics, Inc.’s financial performance and results of operations, including expectations regarding revenue and guidance. These statements are based on management’s current expectations, forecasts, beliefs, estimates, assumptions and information currently available to management. Actual outcomes and results could differ materially from these statements due to a number of factors and such statements should not be relied upon as representing 10x Genomics, Inc.’s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics’ expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. The material risks and uncertainties that could affect 10x Genomics, Inc.’s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the company’s most recently-filed 10-K for the fiscal year ended December 31, 2025 filed on February 12, 2026 and the company’s quarterly report on Form 10-Q for the quarter ended March 31, 2026 to be filed with the U.S. Securities and Exchange Commission (“SEC”), and elsewhere in the documents 10x Genomics, Inc. files with the SEC from time to time.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
10x Genomics, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(In thousands, except share and per share data)
Three Months Ended
March 31,
2026
2025
Products and services revenue
$ 149,896
$ 137,823
License and royalty revenue
947
17,060
Revenue (1)
150,843
154,883
Cost of products and services revenue (2)
44,665
49,438
Gross profit
106,178
105,445
Operating expenses:
Research and development (2)
56,847
64,245
Selling, general and administrative (2)
66,377
89,728
Gain on settlement
—
(9,200)
Total operating expenses
123,224
144,773
Loss from operations
(17,046)
(39,328)
Other income (expense):
Interest income
5,014
3,686
Other income (expense), net
(815)
2,136
Total other income
4,199
5,822
Loss before provision for income taxes
(12,847)
(33,506)
Provision for income taxes
623
852
Net loss
$ (13,470)
$ (34,358)
Net loss per share, basic and diluted
$ (0.10)
$ (0.28)
Weighted-average shares used to compute net loss per share, basic and diluted
128,291,153
122,606,091
__________________________
(1)
The following table represents total revenue by source for the periods indicated (in thousands). Spatial includes the Company’s Visium and Xenium products:
Three Months Ended
March 31,
2026
2025
Instruments
Single Cell
$ 5,223
$ 5,913
Spatial
6,039
8,902
Total instruments revenue
11,262
14,815
Consumables
Single Cell
88,894
84,109
Spatial
40,907
31,247
Total consumables revenue
129,801
115,356
Services
8,833
7,652
Products and services revenue
149,896
137,823
License and royalty revenue
947
17,060
Total revenue
$ 150,843
$ 154,883
(1)
The following table presents revenue by geography based on the location of the customer for the periods indicated (in thousands):
Three Months Ended
March 31,
2026
2025
Americas
United States*
$ 76,693
$ 86,818
Americas (excluding United States)
3,406
3,752
Total Americas
80,099
90,570
Europe, Middle East and Africa
36,852
31,895
Asia-Pacific
China
15,837
16,883
Asia-Pacific (excluding China)
18,055
15,535
Total Asia-Pacific
33,892
32,418
Total revenue
$ 150,843
$ 154,883
*
Includes license and royalty revenue.
(2)
Includes stock-based compensation expense as follows:
Three Months Ended
March 31,
(in thousands)
2026
2025
Cost of revenue
$ 1,918
$ 2,481
Research and development
10,695
14,106
Selling, general and administrative
10,029
14,489
Total stock-based compensation expense
$ 22,642
$ 31,076
10x Genomics, Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
(In thousands)
March 31,
2026
December 31,
2025
Assets
Current assets:
Cash and cash equivalents
$ 490,285
$ 473,966
Marketable securities
49,563
49,443
Accounts receivable, net
39,031
47,013
Other receivables
17,106
35,480
Inventory
53,487
56,341
Prepaid expenses and other current assets
20,261
22,208
Total current assets
669,733
684,451
Property and equipment, net
220,591
226,711
Operating lease right-of-use assets
58,390
60,450
Goodwill
4,511
4,511
Intangible assets, net
59,910
62,329
Other noncurrent assets
2,624
2,913
Total assets
$ 1,015,759
$ 1,041,365
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable
$ 17,425
$ 12,733
Accrued compensation and related benefits
21,506
42,500
Accrued expenses and other current liabilities
33,680
39,971
Deferred revenue
24,342
23,902
Operating lease liabilities
11,330
10,985
Contingent consideration, current
5,315
23,363
Total current liabilities
113,598
153,454
Contingent consideration, noncurrent
1,222
1,237
Operating lease liabilities, noncurrent
70,059
73,376
Deferred revenue, noncurrent
10,138
10,501
Other noncurrent liabilities
6,418
6,471
Total liabilities
201,435
245,039
Commitments and contingencies
Stockholders’ equity:
Preferred stock
—
—
Common stock
2
2
Additional paid-in capital
2,338,269
2,306,690
Accumulated deficit
(1,524,061)
(1,510,591)
Accumulated other comprehensive income
114
225
Total stockholders’ equity
814,324
796,326
Total liabilities and stockholders’ equity
$ 1,015,759
$ 1,041,365
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-reports-first-quarter-2026-financial-results-302766095.html
SOURCE 10x Genomics, Inc.
You may like
Technology
Crown Capital Announces Proposed Debenture Amendments and Default Waiver For 12% Secured Subordinated Debentures
Published
3 hours agoon
July 4, 2026By
CALGARY, AB, July 3, 2026 /CNW/ – Crown Capital Partners Inc. (“Crown” or the “Corporation”) (TSX: CRWN) today announced that, further to its news release dated June 25, 2026 announcing the entering into of a share purchase agreement (the “Galaxy Transaction”) to sell all of the issued and outstanding shares (the “Galaxy Shares”) of its subsidiary, Galaxy Broadband Communications Inc. to Calian Group Ltd. (TSX: CGY) (“Calian”), it will seek approval of the holders (the “Debentureholders”) of the Corporation’s 12% Secured Subordinated Debentures (TSX: CRWN.NT) due December 31, 2026 (the “Debentures”) for a resolution (the “Debentureholder Resolution”) at a meeting of the Debentureholders to be held at the offices of the Corporation, 121 King Street West, Suite 840, Toronto, Ontario, on August 11, 2026 at 10:00 a.m. (Eastern Time) (the “Meeting”).
If approved by the Debentureholders at the Meeting, the Debentureholder Resolution would:
authorize and approve certain amendments (the “Debenture Amendments”) to the Corporation’s second amended and restated trust indenture dated October 25, 2024 (the “Indenture”) between the Corporation and TSX Trust Company (the “Debenture Trustee”) and authorize the Debenture Trustee to enter into a third amended and restated trust indenture with the Corporation (the “Amended and Restated Indenture”) to:
(i) permit the Corporation to complete the Galaxy Transaction free of the security interest created by the Indenture notwithstanding that the sale of the Galaxy Shares to Calian would be a sale of assets of the Corporation not in the ordinary course of business of the Corporation and, accordingly, not permitted under the Indenture;
(ii) extend the maturity date of the Debentures from December 31, 2026 to December 31, 2027;
(iii) grant the Corporation the option to further extend the maturity date of the Debentures for up to one year to December 31, 2028, provided that: (A) the Corporation pays all outstanding interest on the Debentures as at December 31, 2027; (B) the Corporation pays a fee of 0.1% of the principal amount of the Debentures to the Debentureholders for each month that the maturity date of the Debentures is extended, such fee to be paid concurrently with the interest due on the Debentures as at December 31, 2027; and (C) such option is exercised at least 30 days prior to December 31, 2027 and may only be exercised once;
(iv) amend the interest payment dates from occurring annually on December 31 of each year to only at maturity or redemption of the Debentures;
(v) prohibit the Corporation from paying any dividends on the common shares of the Corporation (“Common Shares”) or acquiring any Common Shares by way of an issuer bid while any Debentures remain outstanding;
(vi) eliminate the ability of the Corporation to incur Senior Indebtedness (as defined in the Amended and Restated Indenture) following the repayment of the senior indebtedness of the Corporation to Sandton Investments IX (Luxembourg) S.A.R.L. (the “Sandton Indebtedness”) and the redemption of the $1,500,000 principal amount of unlisted debentures of the Corporation (the “2025 Debentures”), other than up to $1,000,000 of Senior Indebtedness to be used for general corporate purposes;
(vii) remove the requirement that the Corporation use its best efforts to maintain the listing of the Common Shares and the Debentures on the Toronto Stock Exchange (“TSX”); and
(viii) eliminate the ability of the Corporation to satisfy interest obligations by issuing and selling its shares through investment bankers under the Indenture; and
waive the default by the Corporation under the Indenture for the failure to pay the outstanding interest on the Debentures from June 30, 2024 to December 31, 2025 (the “Deferred Interest Payment”) on December 31, 2025 (the “Default Waiver”), subject to the requirement that the Corporation pay: (a) the Deferred Interest Payment; and (b) interest on the Debentures from January 1, 2026 to June 30, 2026 (the “June 2026 Interest Payment”), to Debentureholders within 30 days of the completion of the Galaxy Transaction (the “Deferred Interest Payment Deadline”). The Deferred Interest Payment and the June 2026 Interest Payment will be made to Debentureholders holding Debentures as of a record date to be set by the Corporation following the effective date of the Debenture Amendments. In the event that the Deferred Interest Payment is not made by the Deferred Interest Payment Deadline, the Default Waiver will be of no further force or effect.
The board of directors of the Corporation believe that the Debenture Amendments and Default Waiver provide the following advantages:
Completion of Galaxy Transaction: The Debenture Amendments will allow the Corporation to complete the Galaxy Transaction. Without the Debenture Amendments, the Corporation will not be able to complete the Galaxy Transaction.Payment of the Deferred Interest Payment and the June 2026 Interest Payment: If the Galaxy Transaction is completed, the Debentureholders will receive: (a) the Deferred Interest Payment, which will be approximately $161.82 per $1,000 principal amount of Debentures; and (b) the June 2026 Interest Payment, which will be approximately $60.00 per $1,000 principal amount of Debentures.Payment of Sandton Indebtedness: If the Galaxy Transaction is completed, a large portion of the net proceeds from the Galaxy Transaction will be used to repay the entire amount of the Sandton Indebtedness. This will significantly reduce the amount of the Corporation’s debt that ranks in priority to the Debentures.Redemption of 2025 Debentures: If the Galaxy Transaction is completed, a portion of the net proceeds from the Galaxy Transaction will be used to redeem the 2025 Debentures in accordance with their terms. This will further reduce the amount of the Corporation’s debt that ranks in priority to the Debentures.Elimination of Senior Indebtedness: If the Galaxy Transaction is completed, following the repayment of the Sandton Indebtedness and the redemption of the 2025 Debentures, the Corporation will no longer have any Senior Indebtedness ranking in priority to the Debentures. The Debenture Amendments will prohibit the Corporation from incurring any additional Senior Indebtedness in excess of $1,000,000. This will greatly improve the relative security position of the Debentures.Extension of Maturity Date: The extension of the maturity date, and the option granted to the Corporation to extend the maturity date for an additional year, will afford Debentureholders a longer period of time during which to receive interest at a favourable rate and to potentially receive a fee of 0.1% for each month that the maturity date of the Debentures is extended past December 31, 2027. The extension of the maturity date will also provide the Corporation with additional time to fund the repayment of the Debentures from the proceeds of asset sales or otherwise.Prohibition of Dividends and Issuer Bids: The removal of the ability of the Corporation to pay dividends on the Common Shares or undertake any issuer bids for Common Shares while any Debentures remain outstanding provides significant incentive for the Corporation to repay the Debentures and ensures that holders of Common Shares will not receive preferential treatment over holders of Debentures.
The effective date of the Debenture Amendments will be the later of: (a) a minimum of five trading days following the approval of the Debentureholder Resolution; and (b) immediately prior to the closing of the Galaxy Transaction once all conditions precedent to the closing of the Galaxy Transaction have been satisfied or waived, other than the release of funds and those relating to the Debenture Amendments. Further particulars of the expected benefits of the Debenture Amendments and Default Waiver are described in the management information circular of the Corporation relating to the Meeting (the “Circular”) and the related meeting materials, which will be made available under the Corporation’s profile on SEDAR+ at www.sedarplus.ca and mailed to the Debentureholders in the coming days.
The Debentureholder Resolution will only be effective if passed by an extraordinary resolution of the holders of at least 66 ⅔% of the principal amount of the Debentures present in person or by proxy at the Meeting and entitled to vote in respect of the Debentureholder Resolution. Management recommends that Debentureholders vote in favor of the Debentureholder Resolution.
The TSX has conditionally approved the Debenture Amendments. The Debenture Amendments remain subject to the final approval of the TSX.
Debentureholders may vote on or before 10:00 a.m. (Eastern Time) on August 7, 2026 by following the voting instructions set out in the Circular. Only Debentureholders of record at the close of business on July 8, 2026 will be entitled to vote at the Meeting.
FORWARD-LOOKING STATEMENTS
This news release contains certain “forward looking statements” and certain “forward looking information” as defined under applicable Canadian and U.S. securities laws. Forward-looking statements can generally be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. Forward-looking statements in this news release include, but are not limited to, statements, management’s beliefs, expectations or intentions regarding the Debenture Amendments, the Default Waiver, the expected timing and completion of the Galaxy Transaction, the use of proceeds of the Galaxy Transaction, the anticipated payment of the Deferred Interest Payment and the June 2026 Interest Payment, the benefits of the Debenture Amendments and the Default Waiver and the receipt of Debentureholder approval. Forward-looking statements are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements are subject to various risks and uncertainties concerning the specific factors identified in the Crown’s periodic filings with Canadian securities regulators. See Crown’s most recent annual information form for a detailed discussion of the risk factors affecting Crown. Crown undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents management’s best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.
SOURCE Crown Capital Partners Inc.
Technology
Menu Order AI Appoints Krishna Kumar as Chief Operating Officer
Published
5 hours agoon
July 3, 2026By
Menu Order AI welcomes veteran AI and technology executive Krishna Kumar as Chief Operating Officer to accelerate enterprise growth, restaurant partnerships, and AI innovation.
NEEDHAM, Mass., July 3, 2026 /PRNewswire/ — Menu Order AI today announced the appointment of Krishna Kumar as Fractional Chief Operating Officer (COO), strengthening the company’s leadership team as it expands its AI-powered platform for restaurants and consumers.
Krishna brings decades of experience leading artificial intelligence, software development, enterprise technology, and global product initiatives. Throughout his career, he has built high-performing teams and helped organizations transform innovative ideas into scalable technology platforms.
As Chief Operating Officer, Krishna will oversee engineering, product operations, strategic partnerships, and enterprise growth while helping scale Menu Order AI’s restaurant and consumer platforms.
“Krishna’s operational expertise and deep understanding of artificial intelligence make him an invaluable addition to our leadership team,” said Melissa Butler, Founder & CEO of Menu Order AI. “As we continue expanding our restaurant partnerships and consumer platform, his leadership will help accelerate our mission of becoming the intelligence layer between restaurant menus and diners.”
Since launching, Menu Order AI has grown to more than 150,000 downloads and averages approximately 35,000 monthly active users. The platform helps guests instantly discover personalized menu recommendations based on their dietary preferences and nutrition goals, including high-protein, low-carb, and GLP-1-friendly options.
The company is also expanding its restaurant QR platform, enabling guests to scan a QR code at participating restaurants and receive AI-powered menu recommendations instantly without downloading an app.
“I am excited to join Menu Order AI during such an important stage of its growth,” said Krishna Kumar, Chief Operating Officer. “Artificial intelligence is transforming every aspect of the restaurant industry, and Menu Order AI is uniquely positioned to improve both the guest experience and restaurant performance. I look forward to helping build the next phase of the company’s growth.”
Menu Order AI continues to expand partnerships across restaurants, hospitality, and healthcare while developing AI solutions that simplify one of the most common consumer decisions—what to order.
About Menu Order AI
Menu Order AI is an AI-powered restaurant recommendation platform that helps consumers make smarter dining decisions by providing personalized menu recommendations based on individual nutrition goals and dietary preferences. The platform serves dine-in, takeout, delivery, and drive-thru guests while helping restaurant partners enhance the guest experience through AI-powered menu guidance.
For more information, visit www.menuorderai.com.
Menu Order AI – Apple App StoreMenu Order AI – Google Play Store
Melissa Butler
Founder / CEO
Menu-Order AI
melissa@menuorderai.com
This release was issued through WebWire®. For more information, visit http://www.webwire.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/menu-order-ai-appoints-krishna-kumar-as-chief-operating-officer-302817831.html
SOURCE MENU – ORDER AI
Technology
Conformal Coatings Market worth $2.19 billion by 2031 – Exclusive Report by MarketsandMarkets™
Published
5 hours agoon
July 3, 2026By
DELRAY BEACH, Fla., July 3, 2026 /PRNewswire/ — According to MarketsandMarkets™, “Conformal Coatings Market by Type (Acrylic, Silicone, Epoxy, Urethane, Parylene, Other types), By End-use Industry (Consumer Electronics, Automotive, Aerospace & Défense, Industrial, Telecommunication, Other End-use Industries), and Region – Global Forecast to 2031″, The conformal coatings market is projected to grow from USD 1.66 billion in 2026 and to reach USD 2.19 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=216347388
Conformal Coatings Market Size & Forecast:
Market Size Available for Years: 2022-20312026 Market Size: USD 1.66 billion2031 Projected Market Size: USD 2.19 billionCAGR (2026-2031): 5.7%
Conformal Coatings Market Trends & Insights:
The protection of electronic assemblies from environmental hazards such as water, dust, and chemicals is becoming more essential with the increase in demand for electronics. This increase in demand for electronics has led to increased interest in using conformal coatings as a method of improving reliability and lifespan of sensitive electronic components. There is an increasing demand for conformal coatings across all industries including automotive, electronics, aerospace, telecommunications, industrial automation, healthcare and renewable energy, where electronic systems must operate in extreme conditions on a consistent and reliable basis. Manufacturers and end-users are selecting conformal coatings to provide added circuit board protection, reduce maintenance, extend the useful life of products, and minimize product failures due to environmental conditions and electrical degradation. The performance of conformal coatings continues to improve through advancements in coating formulations, selective coatings, UV cure technology, automated dispensing equipment and inspection methods. Enhanced dielectric insulation, thermal stability, chemical resistance, moisture resistance, and mechanical durability provided by these advancements enable coated electronic assemblies to endure extreme temperatures, high humidity, low humidity, vibration, salt fog, and aggressive chemical environments. These improvements are critical for the future of electric vehicles, advanced electronic systems, 5G infrastructure, renewable energy installations, industrial IoT devices and medical electronics, all of which will require operational reliability for an extended period.Asia Pacific accounted for a significant share of 75.1% in 2025.By type, the acrylic segment accounted for 37.5% of the conformal coatings market in 2025.By end-use industry, the automotive segment dominated the market in 2025, with a share of 30.7%.Henkel AG & Co. KGaA (Germany), Illinois Tool Works Inc. (ITW) (US), Shin-Etsu Chemical Co., Ltd. (Japan), and Dow Inc. (US) were identified as star players in the conformal coatings market given their strong share and product footprint.Europlasma NV (Belgium), Specialty Coating Systems Inc. (US), CHT Germany GmbH (Germany), AI Technology, Inc. (US), Master Bond (US), Aculon (US), and Percision Coatings Inc. (US) have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
Browse in-depth TOC on “Conformal Coatings Market”
280 – Tables
80 – Figures
300 – Pages
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=216347388
Conformal coatings are chemical-resistant, thin, solid forms of flexible material, typically applied to electronic assemblies to protect against moisture, dust, limited chemicals, corrosion, temperature fluctuations, and all other possible atmospheric contaminants. The importance of conformal coatings lies in the enhancement of reliability, durability, and life span of electronic components used in the automotive industry, consumer electronics, telecommunications equipment, aerospace/defense systems, industrial automation, medical devices, and renewable energy applications. There are many different chemistries utilized for conformal coatings: acrylic, silicone, polyurethane, epoxy, and parylene. Each type of conformal coating has unique performance properties and capabilities, depending on the application. Coatings can be applied to assemblies by several methods: spraying, dipping, brushing, selective coating, or vapor deposition. If applied correctly, conformal coatings create a thin (0.001 – 0.010 inch), even, protective layer. After application, the coatings are “cured” by one of many ways to achieve the required physical, electrical, and environmental performance properties. Coatings are grouped by chemistry into 5 broad categories: acrylic, silicone, polyurethane, epoxy, and parylene. When correctly applied, conformal coatings prevent electrical-related failures due to corrosion, leaking current, or contamination, thus allowing electronic systems to function reliably in extreme or very harsh environments for extended periods of time.
By type, the silicone segment will witness the fastest CAGR during the forecast period.
The silicone segment is expected to account for the fastest CAGR in the conformal coatings market during the forecast period. The silicone-based formulation provides excellent performance in extreme operating conditions such as very high or low temperatures, high humidity, extreme vibration, and exposure to corrosive chemicals. Silicone conformal coatings are well-suited to protect electronics that operate in these conditions, as they provide excellent thermal stability, flexibility, moisture resistance, and dielectric insulation. The silicone formulation differs from many conventional coating materials because it will maintain its ability to protect electronic assemblies over the entire temperature range rather than degrade as other conventional materials do. Therefore, silicone conformal coatings will continue to be the preferred choice for manufacturers of electronic devices that require long-term protection from these types of damage and to ensure reliable operation when operated in an industrial setting. The demand for silicone conformal coatings will continue to be driven by the increasing deployment of electric vehicles, advanced driver assistance systems (ADAS), renewable energy systems, aerospace electronics, telecommunications infrastructure, and industrial automation equipment. All these applications need added protection from environmental stressors that can cause corrosion, electrical leakage, and premature failure of sensitive electronic components over time. As the trend toward smaller electronic devices continues to grow and power densities increase, the need for a coating material that has durable protective capabilities without hindering performance will also increase. Manufacturers will increasingly recognize the importance of having durable and reliable silicone conformal coatings, and therefore, the silicone conformal coating segment of the conformal coating market is expected to have the highest growth of any type during the forecast period.
By end-use industry, the telecommunication segment will record the fastest CAGR during the forecast period.
The telecommunications segment is expected to account for the fastest CAGR in the conformal coatings market during the forecast period. This is due to the rapid development of 5G networks, fiber optic communication infrastructure, edge computing facilities, and data transmission systems globally. The equipment used in telecommunications now requires increasingly complex electronic assemblies, printed circuit boards, antennas, routers, switches, and base station components that provide reliable service regardless of the weather or other external influences. The use of conformal coatings helps protect these sensitive electronic parts from factors such as humidity, dust particles, rust, saline, chemicals, and temperature variation that could jeopardize network reliability and provide operational efficiency. The increasing number of 5G base stations being installed outdoors, combined with the development of distributed communication networks, has increased the need for more advanced conformal coating solutions that can provide a longer-lasting level of protection from the elements. Furthermore, investments in cloud computing, data center development, IoT connectivity, and next-generation communications technology are increasing the demand for high-reliability electronic products that will have an extended service life. The growing availability of improved coating materials with superior dielectric insulation properties, enhanced thermal stability, and improved environmental resistance is also accelerating the growth of the overall market. Thus, the telecommunications sector is expected to be one of the most rapidly expanding end-user sectors for conformal coatings throughout the forecast period.
Request Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=216347388
Asia Pacific will record the fastest CAGR during the forecast period.
Asia Pacific is expected to account for the fastest CAGR in the conformal coatings market during the forecast period, as the electronics manufacturing sector continues to grow, automotive production increases, and more investments are made within superior communication infrastructure across the area. Major global suppliers of semiconductors, printed circuit boards (PCBs), consumer electronics, telecommunications equipment, and industrial electronic systems can be found in countries such as China, Japan, South Korea, India, Taiwan, and other Southeast Asian nations. The fact that there has been such an increase in producing these electronic devices means that there will be more demand for conformal coatings to protect electronic components from moisture, corrosion, dust, and chemicals. There is also an increasing number of electric vehicles being produced, along with batteries and ADAS (advanced driver-assisted systems), which are automotive electronics. All these factors will lead to increased use of conformal coating technologies across the industry. In addition, the deployment of 5G networks, expansion of data centers, industrial automation, and investments in renewable energy infrastructure provide significant opportunities for electronic protection. The demand for modern conformal coatings will increase dramatically as the desire for reliability, durability, and performance in electronic assemblies continues to grow. Thus, Asia Pacific will record the highest growth rate of any region in the world conformal coatings market throughout the forecast period.
Key Players
The conformal coatings market comprises major players such as Henkel AG & Co. KGaA (Germany), Illinois Tool Works Inc. (ITW) (US), Shin-Etsu Chemical Co., Ltd. (Japan), Dow Inc. (US), H.B. Fuller (US), Element Solutions Inc (ESI), ALTANA AG (Germany), Chase Corp. (US), Dymax (US), and MG Chemicals (Canada) are covered in the conformal coatings market. Partnerships, acquisitions, and expansions are some of the major strategies adopted by these key players to enhance their positions in the conformal coatings market.
Get access to the latest updates on Conformal Coatings Companies and Conformal Coatings Market Size
Browse Adjacent Market: Coatings Adhesives Sealants and Elastomers Market Research Reports & Consulting
Related Reports:
Silicone Elastomers Market – Global Forecast to 2030
Europe Architectural Coatings Market – Global Forecast to 2031
Medical Adhesives Market – Global Forecast to 2031
Paint Protection Films Market – Global Forecast to 2030
Isocyanates Market – Global Forecast to 2030
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/conformal-coatings-market-worth-2-19-billion-by-2031—exclusive-report-by-marketsandmarkets-302817486.html
Bitcoin P&L ratio falls to 43-month low
Crown Capital Announces Proposed Debenture Amendments and Default Waiver For 12% Secured Subordinated Debentures
Menu Order AI Appoints Krishna Kumar as Chief Operating Officer
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology4 days agoVertex Adds Chad Paulin as new AI Strategy Officer
-
Coin Market5 days agoDubai crypto market hits 50 licensed firms after new VARA approval
-
Technology5 days agoFIREWORKS BY GRUCCI, AMERICA’S FIRST FAMILY OF FIREWORKS, LIGHTS UP AMERICA’S 250TH WITH HISTORIC CELEBRATIONS COAST TO COAST
-
Technology5 days agoHigh Templar Tech Announces Final Results of Modified Dutch Auction Tender Offer
-
Technology5 days ago
How can a company navigate business cycles and achieve lasting success: Chairman and President of Midea Group
-
Coin Market5 days agoExcessive AI spending risks global financial consequences, BIS warns
-
Technology5 days agoMinesto strengthens global expansion capabilities with the appointment of energy industry executive Philippe Kavafyan to its Board
-
Technology5 days agoLIGHT AI ACHIEVES ISO 13485 AND MDSAP CERTIFICATION, ADVANCING REGULATORY READINESS FOR HEALTH CANADA SUBMISSION OF QUICKSCAN™ SOFTWARE PLATFORM
